4th Quarter - Report
SMITH & NEPHEW, INC. for SMITH & NEPHEW, INC.
Firm
Client
Income
—
Expenses
$245,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reform of FDA's 510(k) process for the market clearance of medical devices. Reform of FDA's pre-market approval process for Class III devices.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | Spec. Assist., HHS; Counsel, Sen. Budget Com. |
Medicare/Medicaid MMM
Durable Medical Equipment (DME) Rule for the Medicare program, first published on July 8, 2011. DME competitive bidding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | Spec. Assist, HHS; Counsel, Sen. Budget Com. |
Taxation/Internal Revenue Code TAX
S. 17 -- Medical Device Access and Innovation Protection Act H.R. 436 -- Medical Device Access and Innovation Protection Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | Spec. Assist., HHS; Counsel, Sen. Budget Com. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.